Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

A novel therapeutic peptide targeting myocardial reperfusion injury.

Boisguérin P, Covinhes A, Gallot L, Barrère C, Vincent A, Busson M, Piot C, Nargeot J, Lebleu B, Barrère-Lemaire S.

Cardiovasc Res. 2019 May 30. pii: cvz145. doi: 10.1093/cvr/cvz145. [Epub ahead of print]

PMID:
31147690
2.

Acute and long-term cardioprotective effects of the Traditional Chinese Medicine MLC901 against myocardial ischemia-reperfusion injury in mice.

Vincent A, Covinhes A, Barrère C, Gallot L, Thoumala S, Piot C, Heurteaux C, Lazdunski M, Nargeot J, Barrère-Lemaire S.

Sci Rep. 2017 Oct 31;7(1):14701. doi: 10.1038/s41598-017-14822-x.

3.

Cardiac mGluR1 metabotropic receptors in cardioprotection.

Vincent A, Sportouch C, Covinhes A, Barrère C, Gallot L, Delgado-Betancourt V, Lattuca B, Solecki K, Boisguérin P, Piot C, Nargeot J, Barrère-Lemaire S.

Cardiovasc Res. 2017 May 1;113(6):644-655. doi: 10.1093/cvr/cvx024.

PMID:
28453728
4.

Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.

Roy R, Evens AM, Patton D, Gallot L, Larson A, Rademaker A, Cilley J, Spies S, Variakojis D, Gordon LI, Winter JN.

Leuk Lymphoma. 2013 Mar;54(3):497-502. doi: 10.3109/10428194.2012.722215. Epub 2012 Sep 11.

PMID:
22906230
5.

Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.

Eklund J, Kozloff M, Vlamakis J, Starr A, Mariott M, Gallot L, Jovanovic B, Schilder L, Robin E, Pins M, Bergan RC.

Cancer. 2006 Jun 1;106(11):2459-65.

6.

Safety and efficacy of weekly oral oltipraz in chronic smokers.

Kelley MJ, Glaser EM, Herndon JE 2nd, Becker F, Bhagat R, Zhang YJ, Santella RM, Carmella SG, Hecht SS, Gallot L, Schilder L, Crowell JA, Perloff M, Folz RJ, Bergan RC.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):892-9.

7.

Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.

Takimoto CH, Glover K, Huang X, Hayes SA, Gallot L, Quinn M, Jovanovic BD, Shapiro A, Hernandez L, Goetz A, Llorens V, Lieberman R, Crowell JA, Poisson BA, Bergan RC.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1213-21.

Supplemental Content

Loading ...
Support Center